Exploring the link between type 2 diabetes medications and reduced cancer risk
Recent studies have shed light on the potential benefits of certain type 2 diabetes medications beyond glucose control. Notably, medications classified as glucagon-like peptide receptor agonists (GLP-1RAs), such as Ozempic, have been linked to a reduced risk of several obesity-related cancers. Key findings from recent research A study published in JAMA Network Open highlights that […]
Addressing uterine and endometrial cancer in the Black community
Recent reports highlight a troubling increase in uterine and endometrial cancer fatalities, particularly affecting the Black community in the United States. Despite not leading in incidence rates, Black women are nearly twice as likely to die from endometrial cancer compared to their white counterparts. This disparity underscores the urgent need for targeted health interventions and […]